Short answer
KORU Medical Systems, Inc. (KRMD) filed an 8-K current report with the SEC on November 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 fiscal 2026 results covered quarter ended September 30, 2026.
KORU Medical Systems, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 fiscal 2026 results covered quarter ended September 30, 2026
- Updated fiscal 2026 guidance, potentially affecting earnings expectations and valuation
- Press release and GAAP-to-non-GAAP reconciliation available in Exhibit 99.1
- Management highlighted adjusted EBITDA and adjusted diluted EPS for operating comparability
- Investor conference call scheduled November 10, 2026 at 4:30 p.m. Eastern time
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $11.6M, up 11.2%, led by domestic core growth of 31.6% to $8.1M
- Gross margin expanded to 65.2% from 60.2%, lifting gross profit 20.5% to $7.5M
- Net income reached $0.2M versus a $0.8M loss, with adjusted EBITDA rising to $1.3M
- Full-year revenue guidance raised to $48.0M-$48.5M, while gross-margin guidance increased to 63%-64%
- Cash fell to $7.4M after $0.9M of Q3 usage, though year-end cash guidance rose above $8.0M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other KORU Medical Systems, Inc. 8-K filings
Get the next KRMD 8-K as it lands
Follow KRMD for push alerts, or ask the research agent what this filing means.